Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

RNF122 Activators

The chemical class designated as RNF122 Activators encompasses a group of compounds that influence the ubiquitin-proteasome system (UPS), a cellular mechanism responsible for protein degradation and turnover. These activators can elevate the activity of RNF122, an E3 ubiquitin ligase, by modulating the availability of ubiquitin, inhibiting deubiquitinating enzymes, or by stabilizing proteins that are normally targeted for degradation. The enhanced activity of RNF122 can lead to an increased tagging of substrate proteins with ubiquitin, facilitating their recognition and breakdown by the proteasome. The ubiquitin-proteasome pathway, through which these activators operate, is critical to numerous cellular processes, including cell cycle progression, signal transduction, and the maintenance of cellular homeostasis.

Activators in this class can also impact RNF122 indirectly by affecting related cellular pathways. For instance, the use of proteasome inhibitors can lead to an accumulation of ubiquitinated proteins, creating a cellular environment that necessitates increased E3 ligase function. Similarly, compounds that inhibit the NEDD8-activating enzyme can alter the activity of cullin-RING ligases, thereby potentially influencing the activity of RNF122 within the broader context of the UPS. These activators operate by altering the dynamics of protein ubiquitination and degradation, processes that are integral to the regulation of protein quality and function within the cell. Through these mechanisms, RNF122 activators can play a significant role in modulating the UPS and, by extension, RNF122 activity, without directly interacting with the protein itself.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that could lead to the accumulation of ubiquitinated proteins, which could possibly activate RNF122 due to increased demand for E3 ligase activity.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

A proteasome inhibitor that stabilizes proteins targeted for degradation, which could possibly activate RNF122 to enhance ubiquitination processes.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

An inhibitor of ubiquitin-activating enzyme E1, could possibly activate RNF122 by increasing available ubiquitin levels for ligase action.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor used in cancer therapy that could possibly activate RNF122 by causing a buildup of ubiquitinated proteins.

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

An inhibitor of NEDD8-activating enzyme, affecting cullin-RING ligase activity, which could possibly activate RNF122 by altering the cellular ubiquitination context.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

A proteasome inhibitor that could possibly activate RNF122 by preventing protein degradation and influencing E3 ligase dynamics.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

A modulator of the ubiquitin-proteasome system that could possibly activate RNF122 by affecting the levels of ubiquitinated proteins.

Celastrol, Celastrus scandens

34157-83-0sc-202534
10 mg
$158.00
6
(1)

A natural compound that induces heat shock response and inhibits the proteasome, which could possibly activate RNF122 through a stress response mechanism.